Discure Technologies

Discure Technologies is a clinical-stage medical device company based in Israel, focused on developing a minimally invasive, implantable bioelectronic device to treat degenerative disc disease (DDD), a leading cause of low back pain. The company's flagship product, the Discure System, aims to regenerate spinal discs by actively reintroducing fluid, oxygen, and nutrients, addressing the root cause of disc degeneration rather than just managing symptoms. Currently, the Discure System is undergoing First-in-Human clinical trials in Canada and Italy, marking a significant step toward clinical validation. The company has received notable recognition, including the FDA's Breakthrough Device Designation in 2021 and acceptance into the FDA's Total Product Life Cycle Advisory Program, which supports accelerated development and market access. Discure Technologies is backed by several investors, reflecting strong financial support for its growth and clinical development.

• Employees11